Norges Bank Design Therapeutics, Inc. Transaction History

Norges Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2023	BUY	$11.17 - $20.89 $2.23 Million - $4.18 Million	200,000 New	200,000 $3.23 Million
Q1 2022 May 09, 2022	SELL	$11.17 - $20.89 $2.23 Million - $4.18 Million	-200,000 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$13.64 - $21.41 $2.73 Million - $4.28 Million	200,000 New	200,000 $4.28 Million
Q3 2021 Nov 14, 2022	BUY	$13.99 - $20.03 $2.8 Million - $4.01 Million	200,000 New	200,000 $2.94 Million
Q3 2021 Nov 05, 2021	SELL	$13.99 - $20.03 $2.8 Million - $4.01 Million	-200,000 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$19.02 - $29.78 $3.8 Million - $5.96 Million	200,000 New	200,000 $3.98 Million
Q2 2021 Aug 10, 2021	SELL	$19.02 - $29.78 $3.8 Million - $5.96 Million	-200,000 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$29.52 - $41.49 $5.9 Million - $8.3 Million	200,000 New	200,000 $5.98 Million

103

30.8M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $277M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.